Fierce Biotech article highlights dearth of inclusion in

An important article from industry publication Fierce Biotech highlights the lack of inclusion of the Down syndrome community in Alzheimer’s research. LuMind

Fierce Biotech Summit

Fierce Healthcare's 2023 Women of Influence

AAPI Influence Across Industries

Fierce Biotech's 2022 Fierce 15

Research News - LuMind IDSC Foundation

Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy: Molecular Therapy - Methods & Clinical Development

Clinical trials can make anyone a hero

News – Growing UConn's Research Enterprise with an Inclusive Approach

2022's Fiercest Women in Life Sciences

Executive Interviews at Fierce Biotech Summit 2022

Fierce Biotech's 2022 Fierce 15

Beyond Down Syndrome: The Friedman family turns experience into guidance - LuMind IDSC Foundation

Fierce Healthcare, Fierce Medtech's Rising Stars in Health Tech

Optimizing the manufacturing and antitumour response of CAR T therapy

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States